Baiya International Group Approves 1-for-25 Reverse Stock Split
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 23 2025
0mins
Baiya International Group's board of directors has approved a reverse stock split of the Company's class A ordinary shares, a par value of $0.0001 each, at a ratio of 1-for-25, with a post-Reverse Stock Split par value of $0.0025. The Company is undertaking the Reverse Stock Split with the objective of meeting the minimum $1.00 per Ordinary Share bid requirement for maintaining the listing of the Ordinary Shares on The Nasdaq Capital Market. The Reverse Stock Split will be effective at 04:01 p.m. on Monday, December 29 and the Ordinary Shares will begin trading on a split-adjusted basis when the Nasdaq Stock Market opens for trading on Tuesday, December 30. The Ordinary Shares will continue to trade on The Nasdaq Capital Market under the trading symbol "BIYA" but will trade under the following new CUSIP number: G51400151.
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
Analyst Views on BIYA
About BIYA
Baiya International Group Inc. is a holding company. The Company conducts all of its operations in China through Shenzhen Gongwuyuan Network Technology Co., Ltd. (Gongwuyuan) and its subsidiaries. Through Gongwuyuan, the Company builds a human resource (HR) technology company utilizing its cloud-based Internet platform to provide one-stop crowdsourcing recruitment and software as a service (SaaS)-enabled HR solutions in the employment marketplace (the Gongwuyuan Platform). Its business focuses on job matching services, entrusted recruitment services, project outsourcing services, and labor dispatching services. The Gongwuyuan Platform offers employment matching services. The Company contracts with domestic labor service companies to access the blue-collar labor to provide recruitment facilitation services to customers and employing companies. It connects its customers and employing companies with the available blue-collar labor from either the Company or the HR service companies.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Rapt Therapeutics Acquired by GSK for $58 per Share, Valuing at $2.2 Billion
- Acquisition Deal: GSK has agreed to acquire Rapt Therapeutics for $58 per share, representing an estimated total equity value of $2.2 billion, which will significantly enhance GSK's market position in the biopharmaceutical sector.
- Stock Surge: Rapt Therapeutics' shares jumped 63.4% to $57.36 in pre-market trading, reflecting a positive market reaction to the acquisition, which may attract more investor interest in the company.
- Market Impact: This acquisition not only increases shareholder value for Rapt but may also prompt other biotech firms to consider similar strategic acquisitions to enhance their competitiveness and market share.
- Industry Outlook: With GSK's acquisition, Rapt's product development process is expected to accelerate, potentially leading to faster drug launches and further solidifying GSK's leadership position in the innovative pharmaceuticals market.
Continue Reading
Baiya International Executes 1-for-25 Reverse Stock Split to Maintain Nasdaq Listing
- Reverse Split Decision: Baiya International's board approved a 1-for-25 reverse stock split of its ordinary shares to meet Nasdaq's minimum $1.00 per share listing requirement, thereby ensuring the company's continued presence in the capital market.
- Equity Adjustment Impact: Following the reverse split, the company's outstanding shares will decrease from approximately 29,644,605 to about 1,185,784, significantly reducing the number of shares in circulation and helping to elevate the share price to comply with exchange standards.
- Exchange Notification: The reverse split will take effect at 4:01 PM on December 29, 2025, with ordinary shares beginning to trade on a split-adjusted basis on December 30, 2025, ensuring investors are promptly informed of the equity changes.
- Shareholder Impact Explanation: All ordinary shareholders will be uniformly affected by the reverse split without needing to take any action, which protects shareholder interests and reflects the company's commitment to transparency with its investors.
Continue Reading